Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysis.

IF 4.5 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2025-05-08 DOI:10.1038/s41409-025-02619-w

Wenwen Guo, Haixiao Zhang, Hongye Gao, Yawei Zheng, Mingyang Wang, Wenbin Cao, Rongli Zhang, Qiaoling Ma, Yi He, Weihua Zhai, Donglin Yang, Aiming Pang, Sizhou Feng, Mingzhe Han, Yigeng Cao, Erlie Jiang

引用次数: 0

查看原文本刊更多论文

一项单中心回顾性分析：50-65岁急性髓性白血病/MDS术后高风险患者与标准风险患者预后因素的差异

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.